2022
DOI: 10.3390/ijms23052856
|View full text |Cite
|
Sign up to set email alerts
|

Nanomedicine-Based Delivery Strategies for Breast Cancer Treatment and Management

Abstract: Breast cancer is one of the most common types of cancer among women globally. It is caused by mutations in the estrogen/progesterone receptors and conventional treatment methods are commonly utilized. About 70–80 percent of individuals with the early-stage non-metastatic disease may be cured. Conventional treatment is far less than the optimal ratio, as demonstrated through the high mortality rate of women with this cancer. However, conventional treatment methods like surgery, radiotherapy, and chemotherapy ar… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
32
0
1

Year Published

2022
2022
2024
2024

Publication Types

Select...
9
1

Relationship

1
9

Authors

Journals

citations
Cited by 52 publications
(33 citation statements)
references
References 155 publications
(109 reference statements)
0
32
0
1
Order By: Relevance
“…Mucormycosis has been linked to an increase in iron levels caused by deferoxamine treatment in kidney failure (Ibrahim et al 2008 ). Steroids are widely used to treat COVID-19 and minimize damage produced by the body’s variables (Tagde et al 2022 ) (Howard 1999 ) (Akter et al 2021a ). Organ transplantation, AIDS, poorly controlled diabetes, iron overload, malignancies such as those of the immune system during coronavirus infection.…”
Section: Risk Factorsmentioning
confidence: 99%
“…Mucormycosis has been linked to an increase in iron levels caused by deferoxamine treatment in kidney failure (Ibrahim et al 2008 ). Steroids are widely used to treat COVID-19 and minimize damage produced by the body’s variables (Tagde et al 2022 ) (Howard 1999 ) (Akter et al 2021a ). Organ transplantation, AIDS, poorly controlled diabetes, iron overload, malignancies such as those of the immune system during coronavirus infection.…”
Section: Risk Factorsmentioning
confidence: 99%
“…(V) Appropriate application of novel materials improves the efficiency of drug targeting. Such as new nanocarrier drugs ( 98 ), which can be effectively delivered to the tissue site, so the drug dose and frequency of use can be reduced accordingly, thus reducing the toxic reactions of patients.…”
Section: Wbp2 and Breast Cancer Therapymentioning
confidence: 99%
“…Various drug delivery systems have been developed to overcome the harmful side effects, drug loss and degradation, and poor bioavailability issues associated with drugs (Torchilin, 2001 ; Panyam & Labhasetwar, 2003 ). Surfactants, soluble polymers, microcapsules, cell-penetrating peptides, micelles, lipoproteins, liposomes, and microparticles made up of biodegradable natural or synthetic polymers are examples of some of the most commonly used drug carriers (Reddy & Swarnalatha, 2010 ; Tagde et al., 2022 ). Each nanocarrier has its own merits and demerits therefore, the choice of selection of nanocarrier depends on relevant considerations (Torchilin, 2001 ).…”
Section: Introductionmentioning
confidence: 99%